Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 26.45%1.76B | ---- | 125.14%4.2B | ---- | 40.85%1.39B | ---- | -59.50%1.86B | ---- | -69.38%990.38M |
| Profit adjustment | ||||||||||
| Investment loss (gain) | ---- | 149.99%63.05M | ---- | 47.63%493.75M | ---- | -70.26%-126.13M | ---- | -43.81%334.45M | ---- | 56.44%-74.08M |
| Impairment and provisions: | ---- | 348.72%343.75M | ---- | 35.34%908.04M | ---- | -43.23%76.61M | ---- | -13.65%670.92M | ---- | -24.65%134.95M |
| -Other impairments and provisions | ---- | 510.07%308.91M | ---- | 239.91%491.54M | ---- | 46.64%50.64M | ---- | -54.57%144.61M | ---- | -74.09%34.53M |
| Revaluation surplus: | ---- | -97.49%6.26M | ---- | 9.43%669.04M | ---- | -77.81%249.76M | ---- | -43.22%611.39M | ---- | -3.21%1.13B |
| Asset sale loss (gain): | ---- | 1,637.25%3.14M | ---- | -219.84%-25.71M | ---- | 94.23%-204K | ---- | 109.71%21.45M | ---- | -140.15%-3.54M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 1,637.25%3.14M | ---- | -219.84%-25.71M | ---- | 94.23%-204K | ---- | 109.71%21.45M | ---- | -140.15%-3.54M |
| Depreciation and amortization: | ---- | 2.94%1.96B | ---- | 13.02%4.05B | ---- | -32.20%1.9B | ---- | 5.22%3.59B | ---- | 50.79%2.81B |
| -Amortization of intangible assets | ---- | 38.15%171.03M | ---- | 29.63%359.61M | ---- | -19.32%123.8M | ---- | -23.36%277.42M | ---- | -23.96%153.44M |
| -Other depreciation and amortization | ---- | -79.57%40.88M | ---- | 80.64%358.45M | ---- | 0.44%200.13M | ---- | 222.81%198.44M | ---- | 49.42%199.26M |
| Financial expense | ---- | -37.45%506.53M | ---- | -0.74%1.85B | ---- | --809.83M | ---- | --1.86B | ---- | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 115.40%492.29M | ---- | 30.15%-760.26M | ---- | -231.89%-3.2B | ---- | -211.06%-1.09B | ---- | -85.01%-963.09M |
| Accounts receivable (increase)decrease | ---- | 132.31%3.45B | ---- | -42.81%-11.79B | ---- | -136.79%-10.69B | ---- | -663.94%-8.25B | ---- | -3.65%-4.52B |
| Accounts payable increase (decrease) | ---- | -117.26%-1.4B | ---- | 206.47%9.87B | ---- | 629.88%8.14B | ---- | -59.18%3.22B | ---- | -177.07%-1.54B |
| Special items of business | ---- | -780.10%-34.41M | ---- | -61.39%-198.94M | ---- | -115.69%-3.91M | ---- | 96.38%-123.26M | ---- | 116.58%24.93M |
| Adjustment items of business operations | 510.19%9.83B | 598.19%7.19B | 381.39%5.52B | 234.79%9.46B | 213.63%1.61B | 29.03%-1.44B | -439.72%-1.96B | -84.32%2.83B | -117.24%-1.42B | -153.71%-2.03B |
| Net cash from operations | 510.19%9.83B | 594.46%7.15B | 381.39%5.52B | 242.70%9.26B | 213.63%1.61B | 27.95%-1.45B | -439.72%-1.96B | -81.51%2.7B | -117.24%-1.42B | -155.24%-2.01B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | -48.61%278.21M | -40.38%243.82M | -68.44%52.94M | -24.01%520.09M | -16.64%541.39M | -18.39%408.98M | 90.50%167.72M | 67.20%684.42M | -45.58%649.47M | -32.10%501.14M |
| Sale of fixed assets | -66.39%196.98M | 27.66%164.68M | -76.17%21.83M | 4.27%427.05M | 635.57%586.15M | 127.75%129M | 146.01%91.6M | -29.45%409.55M | -84.61%79.69M | -76.36%56.64M |
| Purchase of fixed assets | -39.89%-2.84B | -49.43%-2.07B | -119.06%-1.53B | 34.83%-3.57B | 35.13%-2.03B | 43.59%-1.38B | -33.62%-696.91M | -53.78%-5.48B | -49.17%-3.13B | -73.45%-2.45B |
| Sale of subsidiaries | 238.79%11.07M | 268.83%11.07M | 10.44%11.04M | --14.18M | 4.68%3.27M | -21.05%3M | 163.16%10M | ---- | -99.23%3.12M | -99.17%3.8M |
| Acquisition of subsidiaries | 97.94%-4.67M | 96.17%-4.67M | -61.39%-19.37M | -18.23%-215.5M | -2,126.02%-226.83M | -1,069.25%-122M | 44.09%-12M | -191.20%-182.27M | 76.32%-10.19M | 32.69%-10.43M |
| Recovery of cash from investments | -20.53%10.98B | -27.80%7.92B | 75.11%4.15B | 128.14%16.51B | 131.44%13.82B | 138.85%10.98B | 31.20%2.37B | -5.15%7.24B | 56.01%5.97B | 32.77%4.59B |
| Cash on investment | 31.89%-11.32B | 47.64%-6.93B | 24.02%-4.68B | -110.65%-19.06B | -124.38%-16.62B | -120.29%-13.23B | -52.24%-6.15B | 13.02%-9.05B | 21.19%-7.41B | -30.76%-6.01B |
| Other items in the investment business | 28.12%-457.79M | 4.05%-452.29M | -32.68%-360.92M | 29.93%-1.26B | 55.80%-636.88M | 38.02%-471.39M | -118.17%-272.02M | -110.90%-1.8B | -31.02%-1.44B | -1.77%-760.53M |
| Net cash from investment operations | 30.91%-3.15B | 69.99%-1.11B | 47.79%-2.35B | 18.89%-6.63B | 13.69%-4.56B | 9.29%-3.69B | -62.03%-4.5B | -30.63%-8.17B | 21.08%-5.28B | -117.04%-4.07B |
| Net cash before financing | 326.64%6.68B | 217.59%6.05B | 149.13%3.17B | 148.13%2.63B | 56.00%-2.95B | 15.46%-5.14B | -193.91%-6.46B | -165.45%-5.47B | -538.13%-6.7B | -445.75%-6.08B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 9.04%27.32B | -28.69%11.28B | -23.31%7.88B | 10.21%37.15B | 45.18%25.05B | 11.27%15.81B | 50.95%10.27B | 234.66%33.71B | 65.67%17.26B | 85.09%14.21B |
| Refund | -17.93%-30.92B | 6.97%-14.23B | 30.47%-4.08B | -65.94%-45.63B | -112.25%-26.22B | -79.27%-15.3B | -76.59%-5.87B | -37.85%-27.5B | 12.05%-12.35B | -13.47%-8.53B |
| Issuance of bonds | -47.61%5.5B | -35.27%5.5B | -50.00%3B | 75.00%10.5B | 162.46%10.5B | 239.94%8.5B | --6B | 140.54%6B | 59.99%4B | -0.01%2.5B |
| Dividends paid - financing | -23.95%-2.82B | 21.38%-1.28B | 19.44%-492.46M | 19.55%-3.14B | 21.33%-2.27B | -39.10%-1.63B | -20.91%-611.29M | 12.94%-3.9B | 30.17%-2.89B | -26.33%-1.17B |
| Absorb investment income | -65.42%144.5M | -64.36%130.05M | -97.41%3.17M | -76.07%527.15M | -80.68%417.89M | 277.34%364.86M | 7,658.67%122.59M | -26.67%2.2B | -14.67%2.16B | -95.59%96.69M |
| Other items of the financing business | 74.75%-681.8M | 73.20%-326.09M | -919.83%-2.21B | -351.89%-3.65B | -1,330.26%-2.7B | -500.85%-1.22B | -147.47%-216.78M | 10.88%-807.98M | -106.60%-188.77M | 42.44%-202.5M |
| Net cash from financing operations | -130.48%-1.46B | -83.58%1.07B | -57.76%4.1B | -143.73%-4.24B | -40.19%4.78B | -5.31%6.54B | 182.41%9.7B | 199.40%9.71B | 6,132.09%7.99B | 93.21%6.9B |
| Effect of rate | 36.08%-346.79M | -3,287.84%-186.43M | -406.57%-167.55M | 19.47%244.75M | -966.94%-542.52M | -101.80%-5.5M | 132.37%54.65M | -73.93%204.87M | -90.60%62.58M | -34.11%306.57M |
| Net Cash | 185.19%5.22B | 409.65%7.12B | 124.54%7.27B | -138.04%-1.61B | 41.78%1.83B | 69.62%1.4B | 161.95%3.24B | 401.66%4.23B | -22.05%1.29B | -84.56%823.52M |
| Begining period cash | -6.71%18.99B | -6.71%18.99B | -6.71%18.99B | 27.89%20.35B | 27.89%20.35B | 27.89%20.35B | 27.89%20.35B | -3.74%15.91B | -3.74%15.91B | -3.74%15.91B |
| Cash at the end | 10.26%23.86B | 19.21%25.92B | 10.34%26.09B | -6.71%18.99B | 25.33%21.64B | 27.58%21.74B | 39.25%23.64B | 27.89%20.35B | -8.41%17.27B | -23.67%17.04B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants Limited | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.